Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart

Genes and Immunity - Tập 5 Số 5 - Trang 330-336 - 2004
Bertram Weiss1, Kerstin Wolk2,3, B Grünberg2, Hans‐Dieter Volk4, Wolfram Sterry5, K. Asadullah2, Robert Sabat2,3
1Enabling Technologies, Schering AG, Berlin, Germany.
2CRBA Dermatology, Schering AG, Berlin, Germany
3Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany
4Institute of Medical Immunology, University Hospital Charite, Berlin, Germany.
5Department of Dermatology, Venerology and Allergology University Hospital Charité Berlin Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Renauld JC . Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003; 3: 667–676.

Kotenko SV . The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev 2002; 13: 223–240.

Dumoutier L, Lejeune D, Colau D, Renauld JC . Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J Immunol 2001; 166: 7090–7095.

Kotenko SV, Izotova LS, Mirochnitchenko OV et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol 2001; 166: 7096–7103.

Xu W, Presnell SR, Parrish-Novak J et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci USA 2001; 98: 9511–9516.

Gruenberg BH, Schoenemeyer A, Weiss B et al. A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immun 2001; 2: 329–334.

Heaney ML, Golde DW . Soluble receptors in human disease. J Leukoc Biol 1998; 64: 135–146.

Fernandez-Botran R . Soluble cytokine receptors: novel immunotherapeutic agents. Expert Opin Invest Drugs 2000; 9: 497–514.

Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC . Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001; 167: 3545–3549.

Dumoutier L, Louahed J, Renauld JC . Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000; 164: 1814–1819.

Dumoutier L, Van Roost E, Colau D, Renauld JC . Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as a hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000; 97: 10144–10149.

Xie MH, Aggarwal S, Ho WH et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000; 275: 31335–31339.

Wolk K, Kunz S, Asadullah K, Sabat R . Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 2002; 168: 5397–5402.

Kotenko SV, Izotova LS, Mirochnitchenko OV et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001; 276: 2725–2732.

Aggarwal S, Xie MH, Maruoka M, Foster J, Gurney AL . Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res 2001; 21: 1047–1053.

Wei CC, Ho TW, Liang WG, Chen GY, Chang MS . Cloning and characterization of mouse IL-22 binding protein. Genes Immun 2003; 4: 204–211.

Lecart S, Morel F, Noraz N et al. IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells. Int Immunol 2002; 14: 1351–1356.

Schwartz S, Zhang Z, Frazer KA et al. PipMaker—a web server for aligning two genomic DNA sequences. Genome Res 2000; 10: 577–586.

Nielsen H, Engelbrecht J, Brunak S, von Heijne G . Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997; 10: 1–6.